Long-term bitcoin holders are selling at the fastest pace since August, while some industry observers suggest the market may ...

Gold and other hard assets are rallying on dollar weakness, but bitcoin is lagging as markets continue to treat it as a liquidity-sensitive risk asset.

Even though the Fed's decision to hold interest rates was widely expected, geopolitical tensions and a rotation into haven ...

Crypto markets fell further overnight as bitcoin and ether extended losses, metals tumbled and liquidation pressure hit ...

"EMA will now review all available data to assess whether this emerging information has an impact on the balance of benefits ...

The approval introduces the first and only anti-CD20 monoclonal antibody shown to improve complete renal response in ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

Data at ASH 2025 highlighted that standardized workflows, education, monitoring innovations, and collaboration are steadily ...

Sarah Larson ONCOLOGY Associate Professor Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...

Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.

Group results In 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 61.5 billion due to strong demand for pharmaceutical products and diagnostic solutions. The appreciation of the Swiss franc ...